PD 141955 and CI-972: 9-deazaguanine analog purine nucleoside phosphorylase inhibitors. I. Suppression of the human mixed lymphocyte reaction (MLR)

This publication has 7 references indexed in Scilit:

• Activities of Two 9-Deazaguanine Analogue Inhibitors of Purine Nucleoside Phosphorylase, CI-972 and PD 141955, in Vitro and in Vivo
  Annals of the New York Academy of Sciences, 1993
• Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955
  Biochemical Pharmacology, 1992
• Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2-d]pyrimidin-4-one (CI-972)
  Journal of Medicinal Chemistry, 1992
• Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors.
  Proceedings of the National Academy of Sciences, 1991
• Selective in vitro inhibition of human molt-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972
  Biochemical and Biophysical Research Communications, 1991
• Pyrrolo[3,2-D]Pyrimidines, a New Class of Purine Nucleoside Phosphorylase (PNP) Inhibitors as Potential T-Cell Selective Immunosuppressive Agents
  Published by Springer Nature ,1991
• Biochemical and Pharmacological Properties of CI-972, a Novel 9-Deazaguanine Analog Purine Nucleoside Phosphorylase (PNP) Inhibitor
  Published by Springer Nature ,1991